We read with a great interest the recent study published by Meier et al., 1 on genetic variants of the ataxia telangiectasiamutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia (T-ALL). They reported a high prevalence (60%) of nucleotide substitution in 16 selected ATM exons in 103 T-ALL, but this prevalence was similar to that of the controls (52%). Interestingly, five alterations located in the coding part of ATM were found to be 2.6-fold higher in T-ALL (13%) than in controls (5%, P ¼ 0.06), associated with a higher white blood cell count at diagnosis (P ¼ 0.05) and with an increased relapse-risk (P ¼ 0.05).
As mentioned by Meier et al., 21 different ATM alterations found in 7/31 (23%) childhood T-ALL samples were reported in our article published in 2003. 2 In our study, 21 different rare variants and nine different well-known polymorphisms were found in all ATM exons, but only rare variants were reported in detail. Therefore, if we considered rare variants and polymorphisms located in the 16 exons analysed by Meier et al. (exons: 9, 12, 15, 17, 19, 20, 24, 31, 32, 39, 40,  41 , 47, 53, 55 and 62), similar prevalence was found with 18/31 T-ALL (58%) harbouring ATM alteration(s). In contrast to the hypothesis proposed by Meier et al., this result suggests that we have the same sensitivity to detect ATM genetic abnormalities, even if the DHPLC conditions used in the two studies were different.
In the last decade, a growing literature has been published concerning the association of genetic polymorphisms and the risk of childhood ALL. Enzymes involved in the folate homeostasis and in the metabolism of carcinogens were largely studied, [3] [4] [5] [6] [7] but polymorphisms in genes involved in DNA repair could be also associated with a modified individual ability to maintain an intact genome in response to genotoxic stress. 8 In the study of Meier et al., the intronic substitution IVS62 þ 8A/C was found with a higher allelic frequency in T-ALL (12/206: 5.8%) as in controls (3/198: 1.5%) (w 2 : P ¼ 0.02). This high frequency was also observed in our 31 T-ALL samples analysed by direct sequencing: two samples were found homozygotes and two others heterozygotes for IVS62 þ 8A/C (allelic frequency: 6/62: 9.7%). This frequency was not found statistically different from the healthy controls (6/114: 5.3%), but the number of samples analysed was small.
As this alteration is located in the vicinity of the splicing site, we performed RT-PCR in order to determine a potential splicing defect. As shown in Figure 1 , no defect was detected, suggesting that this substitution does not interfere with normal splicing.
Altogether, these results suggest that IVS62 þ 8A/C is a polymorphism unlikely to carry biological significance. However, the difference in allelic frequency found by Meier et al. between T-ALL and controls remains intriguing. Larger molecular epidemiology studies are needed to confirm this difference and to detect other ATM polymorphisms possibly involved in childhood ALL susceptibility. RT-PCR analysis of the IVS62 þ 8A/C variant. ATM1 þ / þ : ATM wild-type control; LM4: heterozygous carrier of IVS62 þ 8A/C. Total RNA (RNeasy s Mini Kit, Qiagen GmbH, Hilden, Germany) was extracted from frozen tumor samples. After reverse transcription reaction (Omniscript Reverse Transcriptase, Qiagen GmbH, Hilden, Germany), the cDNA was used as template for a subsequent PCR reaction. The primers were located in the exon 61 (forward) and in the exon 64 (reverse). The PCR products were separated on a 2% agarose gel, purified and sequenced. The 287 pb-fragment is the normal product containing exons 62 and 63. The two faint bands under the 287 pb-fragment were aspecific products. As mentioned by Gumy-Pause et al. 1 in correspondence to our recent study on the clinical value of genetic variants of the ataxia telangiectasia-mutated (ATM) gene in children with T-lineage acute lymphoblastic leukaemia (T-ALL), 2 we suggested that our DHPLC conditions were possibly more sensitive to detect genetic variability in ATM in comparison to the previous study by Gumy-Pause et al. 3 As it becomes clear from their correspondence, beside the reported 21 different genetic alterations in ATM in seven out of 31 T-ALL patients (23%) studied, Gumy-Pause et al. also found nine polymorphisms in 11 other patients (18/31, 58%). This new fact suggests that the frequency of carriers of ATM variants is similar in both studies (60 and 58%, respectively), indicating that the DHPLC conditions were equally sensitive to detect genetic abnormalities in ATM in both studies.
Interestingly, Gumy-Pause et al. confirm in their letter that they also found a relatively higher frequency of the intronic substitution IVS62 þ 8A/C in T-ALL patients compared to controls. Like Gumy-Pause et al., we investigated whether the IVS62 þ 8A/C alteration could trigger alternative splicing of ATM mRNA. We performed RT-PCR with primers located in exon 62 and 65 of a patient carrying this alteration. We could neither observe a difference in size of the PCR product, nor could we confirm minor splicing defects by sequencing analysis.
Remarkably, we observed a correlation between the presence of the IVS62 þ 8A/C variant and a relatively young age of the children with T-ALL (median 1.7-fold younger, Mann-Whitney U, P ¼ 0.01). We did not find this relationship for other variants, D1853N or the five coding alterations that were recently described in our study (see Table 3 of original manuscript). In the study by Liberzon et al., 4 a relation between other ATM variants and a young age was also described. This might suggest that T-ALL patients with specific ATM alterations may be susceptible to develop T-ALL in early childhood. However, the fact that the IVS62 þ 8A/C variant does not result in a different mRNA product does not support this hypothesis. In contrast to silent mutations, about 13% of T-ALL children carry five different coding alterations that may affect the biological function of ATM. As these coding alterations may be more frequently found in T-ALL cases and are linked to higher white blood cell counts and an unfavourable outcome, it is of interest to study the incidence and biological function of these five coding alterations in larger patient cohorts. In addition, it would be interesting to investigate whether genetic variability exists in other (ATM-associated) DNA repair genes and plays a role in susceptibility for T-ALL.
